相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Development of optimized AAV3 serotype vectors: mechanism of high-efficiency transduction of human liver cancer cells
B. Cheng et al.
GENE THERAPY (2012)
Native Molecular State of Adeno-Associated Viral Vectors Revealed by Single-Molecule Sequencing
Philipp Kapranov et al.
HUMAN GENE THERAPY (2012)
High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors
George V. Aslanidi et al.
VACCINE (2012)
Systemic Errors in Quantitative Polymerase Chain Reaction Titration of Self-Complementary Adeno-Associated Viral Vectors and Improved Alternative Methods
Paolo Fagone et al.
HUMAN GENE THERAPY METHODS (2012)
Universal Real-Time PCR for the Detection and Quantification of Adeno-Associated Virus Serotype 2-Derived Inverted Terminal Repeat Sequences
Christine Aurnhammer et al.
HUMAN GENE THERAPY METHODS (2012)
Good Manufacturing Practice Production of Self-Complementary Serotype 8 Adeno-Associated Viral Vector for a Hemophilia B Clinical Trial
James A. Allay et al.
HUMAN GENE THERAPY (2011)
The Assembly-Activating Protein Promotes Capsid Assembly of Different Adeno-Associated Virus Serotypes
F. Sonntag et al.
JOURNAL OF VIROLOGY (2011)
Hemophilia Gene Therapy: A Holy Grail Found
Katherine P. Ponder
MOLECULAR THERAPY (2011)
Novel Properties of Tyrosine-mutant AAV2 Vectors in the Mouse Retina
Hilda Petrs-Silva et al.
MOLECULAR THERAPY (2011)
Long-term Safety and Efficacy Following Systemic Administration of a Self-complementary AAV Vector Encoding Human FIX Pseudotyped With Serotype 5 and 8 Capsid Proteins
Amit C. Nathwani et al.
MOLECULAR THERAPY (2011)
Therapeutic in vivo gene transfer for genetic disease using AAV: progress and challenges
Federico Mingozzi et al.
NATURE REVIEWS GENETICS (2011)
High-Efficiency Transduction of Liver Cancer Cells by Recombinant Adeno-Associated Virus Serotype 3 Vectors
Chen Ling et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2011)
Adeno-Associated Virus Serotype 6 Capsid Tyrosine-to-Phenylalanine Mutations Improve Gene Transfer to Skeletal Muscle
Chunping Qiao et al.
HUMAN GENE THERAPY (2010)
Enhanced Long-Term Transduction and Multilineage Engraftment of Human Hematopoietic Stem Cells Transduced with Tyrosine-Modified Recombinant Adeno-Associated Virus Serotype 2
M. Ariel Kauss et al.
HUMAN GENE THERAPY (2010)
Human Hepatocyte Growth Factor Receptor Is a Cellular Coreceptor for Adeno-Associated Virus Serotype
Chen Ling et al.
HUMAN GENE THERAPY (2010)
Rapid, Simple, and Versatile Manufacturing of Recombinant Adeno-Associated Viral Vectors at Scale
Martin Lock et al.
HUMAN GENE THERAPY (2010)
High-efficiency Transduction and Correction of Murine Hemophilia B Using AAV2 Vectors Devoid of Multiple Surface-exposed Tyrosines
David M. Markusic et al.
MOLECULAR THERAPY (2010)
Proteasome Inhibitors Enhance Gene Delivery by AAV Virus Vectors Expressing Large Genomes in Hemophilia Mouse and Dog Models: A Strategy for Broad Clinical Application
Paul E. Monahan et al.
MOLECULAR THERAPY (2010)
Evidence for the Failure of Adeno-associated Virus Serotype 5 to Package a Viral Genome >= 8.2kb
Yi Lai et al.
MOLECULAR THERAPY (2010)
Characterization of Genome Integrity for Oversized Recombinant AAV Vector
Biao Dong et al.
MOLECULAR THERAPY (2010)
Effect of Genome Size on AAV Vector Packaging
Zhijian Wu et al.
MOLECULAR THERAPY (2010)
A viral assembly factor promotes AAV2 capsid formation in the nucleolus
Florian Sonntag et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
AAV3-mediated transfer and expression of the pyruvate dehydrogenase E1 alpha subunit gene causes metabolic remodeling and apoptosis of human liver cancer cells
Lyudmyla G. Glushakova et al.
MOLECULAR GENETICS AND METABOLISM (2009)
Establishment and Characterization of a Cancer Cell Line Derived From an Aggressive Childhood Liver Tumor
Tina T. -L. Chen et al.
PEDIATRIC BLOOD & CANCER (2009)
Engineering and selection of shuffled AAV genomes: A new strategy for producing targeted biological nanoparticles
Wuping Li et al.
MOLECULAR THERAPY (2008)
Next generation of adeno-associated virus 2 vectors: Point mutations in tyrosines lead to high-efficiency transduction at lower doses
Li Zhong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
A dual role of EGFR protein tyrosine kinase signaling in ubiquitination of AAV2 capsids and viral second-strand DNA synthesis
Li Zhong et al.
MOLECULAR THERAPY (2007)
Self-complementary recombinant adeno-associated viral vectors: Packaging capacity and the role of rep proteins in vector purity
Jianqing Wu et al.
HUMAN GENE THERAPY (2007)
Transfection of mammalian cells using linear polyethylenimine is a simple and effective means of producing recombinant adeno-associated virus vectors
Sharon E. Reed et al.
JOURNAL OF VIROLOGICAL METHODS (2006)
Directed evolution of adeno-associated virus yields enhanced gene delivery vectors
N Maheshri et al.
NATURE BIOTECHNOLOGY (2006)
Packaging capacity of adeno-associated virus serotypes: Impact of larger genomes on infectivity and postentry steps
JC Grieger et al.
JOURNAL OF VIROLOGY (2005)
Total correction of hemophilia A mice with canine FVIII using an AAV 8 serotype
R Sarkar et al.
BLOOD (2004)
Quantification of adeno-associated virus particles and empty capsids by optical density measurement
JM Sommer et al.
MOLECULAR THERAPY (2003)
Ubiquitination of both adeno-associated virus type 2 and 5 capsid proteins affects the transduction efficiency of recombinant vectors
ZY Yan et al.
JOURNAL OF VIROLOGY (2002)
Intracellular trafficking of adeno-associated virus vectors: Routing to the late endosomal compartment and proteasome degradation
AM Douar et al.
JOURNAL OF VIROLOGY (2001)
Endosomal processing limits gene transfer to polarized airway epithelia by adeno-associated virus
DS Duan et al.
JOURNAL OF CLINICAL INVESTIGATION (2000)